Sector revisions Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE 06:00:02 11/09/26 am AEST			5-day change	1st Jan Change
273.00 ^USD	-1.92%		-6.43%	+36.86%

08/09	Charles River Laboratories International Implements Endosafe Cartridge Technology Automated Manufacturing Suite	CI
21/08	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		20
IQVIA HOLDINGS INC.		18
BEONE MEDICINES AG		28
CELLTRION, INC.		22
ASCENDIS PHARMA A/S	-	20
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
ICON PUBLIC LIMITED COMPANY		16
TEMPUS AI, INC.		17
BIO-TECHNE CORPORATION		11
PHARMARON BEIJING CO., LTD.		11
ABIVAX		7
PRAXIS PRECISION MEDICINES, INC.		19
KYMERA THERAPEUTICS, INC.		21
GENSCRIPT BIOTECH CORPORATION		7
PROTAGONIST THERAPEUTICS, INC.		13
IONIS PHARMACEUTICALS, INC.		22
QIAGEN N.V.		15
Average		16
Weighted average by Cap.		19